Boston Scientific (Marlborough, MA) and EndoChoice Holdings (Alpharetta, GA) have entered into a definitive agreement under which Boston Scientific will acquire EndoChoice. Upon completion of the transaction, EndoChoice will become part of the Boston Scientific endoscopy business.
Related: Premier awards EndoChoice with contract for endoscopy equipment, products, and services
EndoChoice develops and commercializes products and services for specialists treating a wide range of gastrointestinal (GI) conditions. Its portfolio includes single-use devices, such as resection and retrieval devices, needles, graspers, and infection control kits. The company also offers pathology services and imaging technologies.
The transaction, which is expected to close in the fourth quarter of 2016, is valued at approximately $210 million.
For more information, please visit www.bostonscientific.com.